Company MELA Sciences Inc Nasdaq
Equities
US55277R3084
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatology Recurring Procedures
64.5
%
| 23 | 63.7 % | 22 | 64.5 % | -6.49% |
Dermatology Procedures Equipment
35.5
%
| 13 | 36.3 % | 12 | 35.5 % | -9.96% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
69.0
%
| 24 | 66.3 % | 23 | 69.0 % | -3.97% |
Other Foreign
12.8
%
| 4 | 10.3 % | 4 | 12.8 % | +14.79% |
China
10.0
%
| 5 | 13.1 % | 3 | 10.0 % | -29.70% |
South Korea
8.2
%
| 4 | 10.3 % | 3 | 8.2 % | -26.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10/18/10 |
Director of Finance/CFO | 42 | 06/21/06 | |
Shmuel Gov
COO | Chief Operating Officer | - | 01/15/01 |
Amandeep Kaur
SAM | Sales & Marketing | - | 04/12 |
Brent Cowgill
SAM | Sales & Marketing | - | 02/21/02 |
John Bagdasarian
PRN | Corporate Officer/Principal | - | 14/22/14 |
Jay Sturm
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 29/18/29 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10/18/10 |
Director/Board Member | 60 | 29/18/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,506,092 | 2,082,935 ( 59.41 %) | 0 | 59.41 % |
Company contact information
STRATA Skin Sciences, Inc.
5 Walnut Grove Drive Suite 140
19044, Horsham
+215 619 3200
http://www.strataskinsciences.com![address MELA Sciences Inc](https://cdn.zonebourse.com/static/address/17595967.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+1.75% | 21TCr | |
+3.42% | 18TCr | |
+31.54% | 16TCr | |
+32.16% | 11TCr | |
+2.24% | 6.46TCr | |
+21.08% | 5.56TCr | |
-1.61% | 4.76TCr | |
-9.11% | 3.69TCr | |
-0.34% | 3.52TCr |